BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12691038)

  • 21. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor.
    Murphy M; Armstrong D; Sepkowitz KA; Ahkami RN; Myskowski PL
    AIDS; 1997 Feb; 11(2):261-2. PubMed ID: 9030382
    [No Abstract]   [Full Text] [Related]  

  • 22. AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count.
    Stebbing J; Powles T; Bower M
    AIDS; 2008 Feb; 22(4):551-2. PubMed ID: 18301078
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of first line therapy including efavirenz and two nucleoside reverse transcriptase inhibitors in HIV-infected children.
    Funk MB; Notheis G; Schuster T; Elanjkal Z; von Hentig N; Stürmer M; Linde R; Dunsch D; Königs C; Wintergerst U; Kreuz W
    Eur J Med Res; 2005 Dec; 10(12):503-8. PubMed ID: 16356864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads.
    Cozzi-Lepri A; De Luca A; Phillips AN; Bongiovanni M; Di Giambenedetto S; Mena M; Moioli MC; Arlotti M; Sighinolfi L; Narciso P; Lichtner M; Cauda R; Monforte Ad; ; ;
    J Infect Dis; 2006 Jul; 194(1):20-8. PubMed ID: 16741878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.
    Tozzi V; Zaccarelli M; Narciso P; Trotta MP; Ceccherini-Silberstein F; De Longis P; D'Offizi G; Forbici F; D'Arrigo R; Boumis E; Bellagamba R; Bonfigli S; Carvelli C; Antinori A; Perno CF
    J Infect Dis; 2004 May; 189(9):1688-95. PubMed ID: 15116307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen.
    Kaplan L; Abrams D; Volberding P
    Cancer Treat Rep; 1986 Sep; 70(9):1121-2. PubMed ID: 3742492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual manifestations of gastrointestinal Kaposi's sarcoma in acquired immunodeficiency syndrome.
    Bieluch VM; Wagner S; Kim K; Freimer EH
    Arch Dermatol; 1988 May; 124(5):652-4. PubMed ID: 3364988
    [No Abstract]   [Full Text] [Related]  

  • 28. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy.
    Aboulafia DM
    Mayo Clin Proc; 1998 May; 73(5):439-43. PubMed ID: 9581584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
    Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
    J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiretroviral therapy. NNRTI (non-nucleoside reverse transcriptase inhibitor)].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():14-6. PubMed ID: 10863304
    [No Abstract]   [Full Text] [Related]  

  • 31. Bigger Foot: Kaposi's Sarcoma.
    Rapaka RR; Fischer M; Finucane TE; Mwakingwe A
    Am J Med; 2015 Sep; 128(9):959-62. PubMed ID: 26055548
    [No Abstract]   [Full Text] [Related]  

  • 32. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
    Albrecht MA; Bosch RJ; Hammer SM; Liou SH; Kessler H; Para MF; Eron J; Valdez H; Dehlinger M; Katzenstein DA;
    N Engl J Med; 2001 Aug; 345(6):398-407. PubMed ID: 11496850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [CROI--presentation of new study results. In a comparison of NNRTI nevirapine is equally effective].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373068
    [No Abstract]   [Full Text] [Related]  

  • 34. Foscarnet and AIDS-associated Kaposi's sarcoma.
    Cordero E; López-Cortés LF; Viciana P; Alarcón A; Pachón J
    AIDS; 1997 Nov; 11(14):1787-8. PubMed ID: 9386820
    [No Abstract]   [Full Text] [Related]  

  • 35. Penile gangrene associated with extensive Kaposi's sarcoma in patients with the acquired immunodeficiency syndrome.
    Klein LT; Lowe FC
    Urology; 1995 Sep; 46(3):425-8. PubMed ID: 7660525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
    Speicher DJ; Sehu MM; Johnson NW; Shaw DR
    J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protease inhibitor saving alternatives].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():16-7. PubMed ID: 10863305
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment for AIDS.
    J Am Osteopath Assoc; 1998 Oct; 98(10):529. PubMed ID: 9821730
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of AIDS-related Kaposi's sarcoma.
    Northfelt DW; Kahn JO; Volberding PA
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):297-310. PubMed ID: 2022595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS-associated Kaposi's sarcoma.
    Kahn JO
    AIDS Clin Rev; 1990; ():115-28. PubMed ID: 1707293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.